1. Home
  2. ICG vs MIRA Comparison

ICG vs MIRA Comparison

Compare ICG & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$0.92

Market Cap

49.4M

Sector

Technology

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.92

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICG
MIRA
Founded
2017
2020
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.4M
43.7M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
ICG
MIRA
Price
$0.92
$0.92
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$5.25
N/A
AVG Volume (30 Days)
69.2K
67.9K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.90
52 Week High
$3.22
$2.45

Technical Indicators

Market Signals
Indicator
ICG
MIRA
Relative Strength Index (RSI) 55.07 41.63
Support Level $0.63 N/A
Resistance Level $1.36 $1.01
Average True Range (ATR) 0.09 0.05
MACD 0.04 -0.00
Stochastic Oscillator 79.39 8.87

Price Performance

Historical Comparison
ICG
MIRA

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: